Research and development of pharmaceuticals in respiratory, immunological, inflammatory diseases, oncology, HIV, and infectious diseases.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: January 2026
This analysis is not yet available in English. Please see the French version.
A
The organization is among the top 5% of organizations with the most committed CSR communication, among comparable organizations.
Leading organizations
ipbs-toulouse (cnrs-ut3)
B
Research and development in cancer, infection, and inflammation to improve therapeutics.
Chiesi SAS
B
Development and marketing of pharmaceuticals in respiratory, neonatology, transplantation, and rare diseases.
AstraZeneca
B
Research, development, production, and marketing of prescription medicines in five therapeutic areas: cardiovascular, renal & metabolism, oncology, respiratory & immunology, rare diseases, and vaccines and immune therapies.
Initiatives identified among leaders
Réduction des émissions de gaz à effet de serre
“AstraZeneca vise à réduire les émissions de gaz à ...” - AstraZenecaPromotion de la santé et allègement de la souffrance des patients
“Chiesi SAS promeut la santé et allège la souffranc...” - Chiesi SASCréation d'un comité de développement durable
“L'IPBS-Toulouse a créé un comité de développement ...” - ipbs-toulouse (cnrs-ut3)58% of similar organizations communicate on CSR issues
+1651 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports